Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunologic Suppression”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00282243
What this trial is testing

Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients

Who this might be right for
Liver Transplantation
Astellas Pharma Inc 70
Early research (Phase 1)Ended earlyNCT00373815
What this trial is testing

Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
University Hospital Tuebingen 10
Testing effectiveness (Phase 2)Study completedNCT03663335
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 418
Post-approval studies (Phase 4)Looking for participantsNCT06354179
What this trial is testing

Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)

Who this might be right for
Liver TransplantationImmunosuppression
University Hospital, Limoges 162
Not applicableUnknownNCT03603548
What this trial is testing

Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial

Who this might be right for
Liver Transplant RejectionImmunosuppression
Medical University of Warsaw 200
Early research (Phase 1)Study completedNCT00005779
What this trial is testing

Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Large-scale testing (Phase 3)Ended earlyNCT00151632
What this trial is testing

Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil After Liver Transplantation

Who this might be right for
Evidence of Liver Transplantation
Rennes University Hospital 195
Not applicableStudy completedNCT00709111
What this trial is testing

Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression

Who this might be right for
HIV Infections
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 34
Post-approval studies (Phase 4)Study completedNCT04786067
What this trial is testing

Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression

Who this might be right for
Kidney Transplant Immunosuppression
University of Texas Southwestern Medical Center 25
Not applicableStudy completedNCT00000627
What this trial is testing

Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome

Who this might be right for
HIV InfectionsHistoplasmosis
National Institute of Allergy and Infectious Diseases (NIAID) 90
Large-scale testing (Phase 3)Ended earlyNCT03995901
What this trial is testing

A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

Who this might be right for
Transplanted Organ Rejection
Talaris Therapeutics Inc. 15
Large-scale testing (Phase 3)Ended earlyNCT00463723
What this trial is testing

Topical FK506 (Tacrolimus) for Prevention of Immune Reactions Following Penetrating Keratoplasty

Who this might be right for
Penetrating Keratoplasty
University Hospital Freiburg
Not applicableUnknownNCT05071573
What this trial is testing

Optimised Electronic Patient Records to Improve Clinical Monitoring of HIV-positive Patients in Rural South Africa

Who this might be right for
HIV Infections
University of Sussex 1,500
Post-approval studies (Phase 4)Ended earlyNCT00656266
What this trial is testing

Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation

Who this might be right for
End-stage Liver DiseaseRenal InsufficiencyRenal Failure
Baylor College of Medicine 13
Not applicableUnknownNCT05514418
What this trial is testing

Effectiveness of Intensive Adherence Counselling Among People Living With HIV/AIDS With Low-level Viraemia in Uganda.

Who this might be right for
HIV/AIDS
Makerere University 136
Post-approval studies (Phase 4)Ended earlyNCT00991510
What this trial is testing

Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients

Who this might be right for
Stable Renal Transplant Recipients
Teva Branded Pharmaceutical Products R&D, Inc. 43
Not applicableStudy completedNCT03397420
What this trial is testing

Family-centered HIV Care, Viral Suppression and Retention in HIV-positive Children, Swaziland

Who this might be right for
HIV Infections
Elizabeth Glaser Pediatric AIDS Foundation 742
Not applicableUnknownNCT05793983
What this trial is testing

S100A8/A9 and Innate Immunity in Liver Disease

Who this might be right for
Cirrhosis, LiverImmune SuppressionLiver Failure, Acute on Chronic+2 more
St George's, University of London 100
Testing effectiveness (Phase 2)Study completedNCT00260689
What this trial is testing

Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia

Who this might be right for
ImmunosuppresionThrombocytopeniaPancytopenia+1 more
National Heart, Lung, and Blood Institute (NHLBI) 136
Testing effectiveness (Phase 2)Study completedNCT00100178
What this trial is testing

New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 126
Next Page